Northern Trust’s SCYNEXIS SCYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $91.1K | Buy |
22,385
+10,438
| +87% | +$64.8K | ﹤0.01% | 4147 |
|
|
2026
Q1 | $87.6K | Buy |
11,947
+2,515
| +27% | +$15.6K | ﹤0.01% | 4134 |
|
|
2025
Q4 | $47.7K | Buy |
9,432
+3,813
| +68% | +$20.8K | ﹤0.01% | 4289 |
|
|
2025
Q3 | $34.6K | Sell |
5,619
-4,717
| -46% | -$31.9K | ﹤0.01% | 4325 |
|
|
2025
Q2 | $55.8K | Sell |
10,336
-6,866
| -40% | -$48.2K | ﹤0.01% | 4211 |
|
|
2025
Q1 | $131K | Sell |
17,202
-1,988
| -10% | -$17.2K | ﹤0.01% | 4052 |
|
|
2024
Q4 | $186K | Buy |
19,190
+6,558
| +52% | +$68.1K | ﹤0.01% | 4013 |
|
|
2024
Q3 | $151K | Sell |
12,632
-133
| -1% | -$1.88K | ﹤0.01% | 3959 |
|
|
2024
Q2 | $204K | Sell |
12,765
-284
| -2% | -$4.39K | ﹤0.01% | 3861 |
|
|
2024
Q1 | $153K | Sell |
13,049
-817
| -6% | -$11.5K | ﹤0.01% | 3970 |
|
|
2023
Q4 | $247K | Buy |
13,866
+7,340
| +112% | +$108K | ﹤0.01% | 3817 |
|
|
2023
Q3 | $119K | Sell |
6,526
-277
| -4% | -$6.62K | ﹤0.01% | 3969 |
|
|
2023
Q2 | $161K | Buy |
6,803
+766
| +13% | +$17.9K | ﹤0.01% | 3901 |
|
|
2023
Q1 | $145K | Buy |
6,037
+768
| +15% | +$10.2K | ﹤0.01% | 3972 |
|
|
2022
Q4 | $65.8K | Hold |
5,269
| – | – | ﹤0.01% | 4213 |
|
|
2022
Q3 | $101K | Buy |
5,269
+661
| +14% | +$12.9K | ﹤0.01% | 4110 |
|
|
2022
Q2 | $69K | Buy |
4,608
+212
| +5% | +$4.08K | ﹤0.01% | 4306 |
|
|
2022
Q1 | $138K | Sell |
4,396
-579
| -12% | -$22.1K | ﹤0.01% | 4253 |
|
|
2021
Q4 | $242K | Buy |
4,975
+324
| +7% | +$15.9K | ﹤0.01% | 4125 |
|
|
2021
Q3 | $197K | Buy |
4,651
+350
| +8% | +$18.3K | ﹤0.01% | 4189 |
|
|
2021
Q2 | $253K | Hold |
4,301
| – | – | ﹤0.01% | 4053 |
|
|
2021
Q1 | $273K | Buy |
4,301
+1,846
| +75% | +$121K | ﹤0.01% | 4011 |
|
|
2020
Q4 | $150K | Buy |
2,455
+264
| +12% | +$12.4K | ﹤0.01% | 4034 |
|
|
2020
Q3 | $77K | Sell |
2,191
-238
| -10% | -$11.7K | ﹤0.01% | 4020 |
|
|
2020
Q2 | $146K | Buy |
2,429
+562
| +30% | +$38.1K | ﹤0.01% | 3833 |
|
|
2020
Q1 | $117K | Hold |
1,867
| – | – | ﹤0.01% | 3790 |
|
|
2019
Q4 | $136K | Buy |
1,867
+463
| +33% | +$38.2K | ﹤0.01% | 3877 |
|
|
2019
Q3 | $120K | Hold |
1,404
| – | – | ﹤0.01% | 3883 |
|
|
2019
Q2 | $147K | Hold |
1,404
| – | – | ﹤0.01% | 3883 |
|
|
2019
Q1 | $170K | Hold |
1,404
| – | – | ﹤0.01% | 3816 |
|
|
2018
Q4 | $54K | Hold |
1,404
| – | – | ﹤0.01% | 4038 |
|
|
2018
Q3 | $135K | Sell |
1,404
-47
| -3% | -$5.55K | ﹤0.01% | 3963 |
|
|
2018
Q2 | $190K | Buy |
1,451
+827
| +133% | +$98.5K | ﹤0.01% | 3877 |
|
|
2018
Q1 | $67K | Buy |
624
+103
| +20% | +$14.2K | ﹤0.01% | 4044 |
|
|
2017
Q4 | $97K | Hold |
521
| – | – | ﹤0.01% | 3976 |
|
|
2017
Q3 | $100K | Hold |
521
| – | – | ﹤0.01% | 3953 |
|
|
2017
Q2 | $75K | Hold |
521
| – | – | ﹤0.01% | 4032 |
|
|
2017
Q1 | $115K | Sell |
521
-43
| -8% | -$10.8K | ﹤0.01% | 3927 |
|
|
2016
Q4 | $144K | Buy |
564
+53
| +10% | +$15.5K | ﹤0.01% | 3828 |
|
|
2016
Q3 | $158K | Buy |
+511
| New | +$108K | ﹤0.01% | 3794 |
|
Other funds holding SCYX
PBM
WP
VCM
EAM
VFT
Northern Trust's SCYX Position: Q2 2026 in Review
Northern Trust increased its SCYNEXIS (SCYX) stake by 87% in Q2 2026, buying an estimated $64.8K and bringing the position to 22,385 shares worth $91.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4147.
Northern Trust first reported a position in SCYX in Q3 2016 and has held it in 40 quarters since. The position peaked at $273K in Q1 2021. 27 funds tracked by Wall St. Rank hold SCYX as of Q2 2026.
- Northern Trust held 22,385 shares of SCYNEXIS worth $91.1K as of Q2 2026.
- Northern Trust bought 10,438 SCYNEXIS shares in Q2 2026, an estimated $64.8K.
- SCYNEXIS made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4147 holding.
- Northern Trust first reported a position in SCYNEXIS in Q3 2016 and has held it in 40 quarters since.
- Northern Trust's SCYNEXIS position peaked at $273K in Q1 2021.
- 27 funds tracked by Wall St. Rank held SCYNEXIS as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.